High-level of intratumoral GITR+ CD4 T cells associate with poor prognosis in gastric cancer
Shouyu Ke(Second Affiliated Hospital of Zhejiang University), Wenyi Zhao(Shanghai Jiao Tong University), Chunchao Zhu(Shanghai Jiao Tong University), Yixian Guo(Renji Hospital), Haigang Geng(Shanghai Jiao Tong University), Yimeng Yu(Shanghai Jiao Tong University), Xu Liu(Peking University), Zeyu Wang(Anhui University), Zizhen Zhang(Peking University), Gang Zhao(Hubei University of Chinese Medicine), Fengrong Yu(Shanghai Jiao Tong University), Xiang Xia(Shanghai University), Bin Li(Shanghai Jiao Tong University), Danhua Xu(Shanghai Jiao Tong University), Feng Xie(Chinese People's Liberation Army), Jieqiong Chen(North China Electric Power University)
Cited by 10
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273
Critical role of <i>all</i> - <i>trans</i> retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions
|Proceedings of the National Academy of Sciences|2014|220